Latest SEC Filings

Texas Community Bancshares, Inc.Texas Community Bancshares Reports 12.9% Net Income Growth, Strategic Developments in Q3 2024

Castellum, Inc.Castellum Reports Mixed Q3 Results with Reduced Loss and Improved Cash Flow

TENAX THERAPEUTICS, INC.Tenax Therapeutics Reports Significant Financial Developments, Including Cash Infusion and Increased Operating Expenses

SilverBox Corp IIISilverBox Corp III Reports Financial Changes, Intends to Dissolve and Liquidate Following Failure to Complete Business Combination

PALVELLA THERAPEUTICS, INC.Pieris Pharmaceuticals Reports Significant Financial Changes in 10-Q Filing, Including Revenue Decline and Improved Net Loss

SmartStop Self Storage REIT, Inc.SmartStop Self Storage REIT Reports Mixed Q3 2024 Results, Net Loss Amid Increased Operating Expenses

INSPIRE VETERINARY PARTNERS, INC.Inspire Veterinary Partners Reports Mixed Q3 Results, Net Loss Improves

KORU Medical Systems, Inc.Koru Medical Systems Reports 16.8% Revenue Growth in Q3 2024, Improves Profitability

ACELYRIN, Inc.Acelyrin Reports Significant Financial Decline, Net Loss Improvement in Latest Quarter

ESPEY MFG & ELECTRONICS CORPEspey Mfg. & Electronics Corp. Reports 21.9% Revenue Growth, Net Income Increase in Q3 2024

VirnetX Holding CorpVirnetX Holding Corporation Reports Revenue Decline, Reduced Expenses, and Improved Net Loss in Q3 and Nine Months 2024

Snail, Inc.Snail, Inc. Reports 150.9% Revenue Growth, Net Income Turnaround in Q3 2024

Oruka Therapeutics, Inc.Oruka Therapeutics Reports $410.9M in Cash, $29.4M in Operating Expenses, and Net Loss of $28.6M in Q3 2024

DIAMONDHEAD CASINO CORPDiamondhead Casino Corporation Reports Net Loss and Stockholders' Deficit Amid Financial Challenges

Hongchang International Co., LtdHongchang International Reports 3,506.86% Revenue Growth, Net Loss Reduction in 9-Month Period Ending September 30, 2024

Metagenomi Therapeutics, Inc.Metagenomi Reports Q3 2024 Financial Results, Net Loss of $18.8M, and Anticipates Continued Investment in Research and Development

GP-Act III Acquisition Corp.GP-Act III Acquisition Corp. Reports Significant Financial Growth and Turnaround in 10-Q Filing

Churchill Capital Corp IX/CaymanChurchill Capital Corp IX Reports Significant Asset Growth, Net Income, and Appoints New Director

OXBRIDGE RE HOLDINGS LtdOxbridge Re Holdings Reports Improved Revenue and Reduced Net Losses in Q3 and Nine-Month Periods

SELLAS Life Sciences Group, Inc.Sellas Life Sciences Reports Improved Financial Position, Reduced Losses in Q3 2024

Revelyst, Inc.Revelyst, Inc. Reports Mixed Financial Results for Q3 and Q2 2024, Despite Sales Decline

Lulu's Fashion Lounge Holdings, Inc.Lulu's Fashion Lounge Reports Decline in Revenue and Increased Net Losses for 13 and 39 Weeks Ended September 29, 2024

Hanover Bancorp, Inc. /MDHanover Bancorp Reports Mixed Results for Q3 2024, with Growth in Assets and Deposits Offset by Rising Expenses and Credit Losses

THC Therapeutics, Inc.THC Therapeutics Reports Significant Changes in Revenue, Expenses, and Financial Performance in Latest Quarter

DUKE Robotics Corp.Duke Robotics Reports Revenue Growth, Net Loss in Latest Quarter